These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3920064)

  • 21. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
    Beyer-Mears A; Ku L; Cohen MP
    Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H; Nozawa Y; Hayano S
    Nippon Ganka Gakkai Zasshi; 1982; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.
    Yue DK; Hanwell MA; Satchell PM; Handelsman DJ; Turtle JR
    Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of high glucose and oxidative stress on lens metabolism, aldose reductase, and senile cataractogenesis.
    Cheng HM; González RG
    Metabolism; 1986 Apr; 35(4 Suppl 1):10-4. PubMed ID: 3083198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aldose reductase inhibitors and late complications of diabetes.
    Benfield P
    Drugs; 1986; 32 Suppl 2():43-55. PubMed ID: 3098544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
    Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
    Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nerve glucose, fructose, sorbitol, myo-inositol, and fiber degeneration and regeneration in diabetic neuropathy.
    Dyck PJ; Zimmerman BR; Vilen TH; Minnerath SR; Karnes JL; Yao JK; Poduslo JF
    N Engl J Med; 1988 Sep; 319(9):542-8. PubMed ID: 3136330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.
    Jaspan JB; Herold K; Bartkus C
    Am J Med; 1985 Nov; 79(5A):24-37. PubMed ID: 3000176
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of an aldose reductase inhibitor (Sorbinil) on diabetic neuropathy and neural function of the retina: a double-blind study.
    Christensen JE; Varnek L; Gregersen G
    Acta Neurol Scand; 1985 Feb; 71(2):164-7. PubMed ID: 3920861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group.
    Arch Ophthalmol; 1990 Sep; 108(9):1234-44. PubMed ID: 2119168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes.
    Jaspan JB; Towle VL; Maselli R; Herold K
    Metabolism; 1986 Apr; 35(4 Suppl 1):83-92. PubMed ID: 3083212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CP-45,634: a novel aldose reductase inhibitor that inhibits polyol pathway activity in diabetic and galactosemic rats.
    Peterson MJ; Sarges R; Aldinger CE; MacDonald DP
    Metabolism; 1979 Apr; 28(4 Suppl 1):456-61. PubMed ID: 122297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and reversal of defective axonal transport and motor nerve conduction velocity in rats with experimental diabetes by treatment with the aldose reductase inhibitor Sorbinil.
    Tomlinson DR; Moriarty RJ; Mayer JH
    Diabetes; 1984 May; 33(5):470-6. PubMed ID: 6202576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of aldose reductase inhibitors in vitro. Effects of enzyme purification and substrate type.
    Poulsom R
    Biochem Pharmacol; 1987 May; 36(10):1577-81. PubMed ID: 3109423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diabetic neuropathy: treatment trial with an aldose reductase inhibitor (Sorbinil)].
    Christensen JE; Larsen AB; Gregersen G
    Ugeskr Laeger; 1987 Nov; 149(46):3111-4. PubMed ID: 3127975
    [No Abstract]   [Full Text] [Related]  

  • 37. Lens metabolism and cellular effects of aldose reductase.
    McLean P; Gonzalez AM; Sochor M; Hothersall JS
    Diabet Med; 1985 May; 2(3):189-93. PubMed ID: 2952418
    [No Abstract]   [Full Text] [Related]  

  • 38. Measurements of tissue sorbitol in diabetes mellitus: enzyme method versus gas-liquid chromatography.
    Malone JI; Lowitt S
    Metabolism; 1992 Feb; 41(2):224-7. PubMed ID: 1736046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M; Fukui H; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sorbinil suppresses glomerular prostaglandin production in the streptozotocin diabetic rat.
    Craven PA; DeRubertis FR
    Metabolism; 1989 Jul; 38(7):649-54. PubMed ID: 2500578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.